Vitamin D receptor polymorphisms and breast cancer risk: Results from the national cancer institute breast and prostate cancer cohort consortium

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 1, 2009, Pages 297-305

  McKay, James D ^a   McCullough, Marjorie L ^b   Ziegler, Regina G ^c   Kraft, Peter ^d   Saltzman, Barbara S ^f   Riboli, Elio ^g   Barricarte, Aurelio ^h   Berg, Christine D ^c   Bergland, Goran ⁱ   Bingham, Sheila ^j   Brustad, Magritt ^k   Bueno de Mesquita, H Bas ^l   Burdette, Laurie ^m   Buring, Julie ^d   Calle, Eugenia E ^b   Chanock, Stephen J ^m   Clavel Chapelon, Françoise ⁿ   Cox, David G ^d   Dossus, Laure ^o   Feigelson, Heather Spencer ^b   Haiman, Christopher A ^p   Hankinson, Susan E ^d,e   Hoover, Robert N ^c   Hunter, David J ^d   Husing, Anika ^o   Kaaks, Rudolph ^o   Kolonel, Laurence N ^f   Le Marchand, Loic ^f   Linseisen, Jakob ^o   McCarty, Catherine A ^q   Overvad, Kim ^r   Panico, Salvatore ^s   Purdue, Mark P ^c   Stram, Daniel O ^p   Stevens, Victoria L ^b   Trichopoulos, Dimitrios ^d   Willett, Walter C ^d,e   Yuenger, Jeffrey ^m   Thun, Michael J ^b   more..

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b AMERICAN CANCER SOCIETY   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^g IMPERIAL COLLEGE LONDON   (United Kingdom)

^h INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

ⁱ LUND UNIVERSITY   (Sweden)

^j INSTITUTE OF METABOLIC SCIENCE   (United Kingdom)

^k UNIVERSITY OF TROMSØ   (Norway)

^l NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^m SAIC FREDERICK INC   (United States)

ⁿ INSTITUT GUSTAVE ROUSSY   (France)

^o GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^p UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^q MARSHFIELD CLINIC   (United States)

^r AARHUS UNIVERSITY HOSPITAL   (Denmark)

^s UNIVERSITY OF NAPLES FEDERICO II   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN D RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; BSMI GENE; CANCER RISK; CONTROLLED STUDY; FEMALE; FOKI GENE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECEPTOR GENE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; LOGISTIC MODELS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RECEPTORS, CALCITRIOL; RISK;

EID: 58349085991     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-0539     Document Type: Article

References (38)

1. Garland FC, Garland CF, Gorham ED, Young JF. Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev Med 1990;19:614-22.
2. Lowe LC, Guy M, Mansi JL, et al. Plasma 25-hydroxy vitamin D concentrations, vitamin Drecep tor genotype and breast cancer risk in a UK Caucasian population. Eur J Cancer 2005;41:1164-9.
3. Bertone-Johnson ER, Chen WY, Holick MF, et al. Plasma 25-hydroxyvitamin Dand 1,25-dihydroxyvitamin Dand risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2005;14:1991-7.
4. Freedman DM, Chang SC, Falk RT et al. Serum levels of vitamin D metabolites and breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev 2008;17:889-94.
5. Colston K, Welsh J. Vitamin Dand breast cancer. In: Feldman D, editor. Vitamin D. Stanford (CA): Elsevier Academic Press; 2005. p. 1663-77.
6. Townsend K, Banwell CM, Guy M, et al. Autocrine metabolism of vitamin Din normal and malignant breast tissue. Clin Cancer Res 2005;11:3579-86.
7. Zinser GM, Welsh J. Vitamin Drecep tor status alters mammary gland morphology and tumorigenesis in MMTV-neu mice. Carcinogenesis 2004;25:2361-72.
8. Chen WY, Bertone-Johnson ER, Hunter DJ, Willett WC, Hankinson SE. Associations between polymorphisms in the vitamin Drecep tor and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2005;14:2335-9.
9. Bretherton-Watt D, Given-Wilson R, Mansi JL, Thomas V, Carter N, Colston KW. Vitamin Dreceptor gene polymorphisms are associated with breast cancer risk in a UK Caucasian population. Br J Cancer 2001;85:171-5.
10. Curran JE, Vaughan T, Lea RA, Weinstein SR, Morrison NA, Griffiths LR. Association of a vitamin Dreceptor polymorphism with sporadic breast cancer development. Int J Cancer 1999;83:723?.
11. Ingles SA, Garcia DG, Wang W, et al. Vitamin D receptor genotype and breast cancer in Latinas. Cancer Causes Control 2000;11:25-30.
12. McCullough ML, Stevens VL, Diver WR, et al. Vitamin D pathway gene polymorphisms, calcium intake, and risk of postmenopausal breast cancer. Breast Cancer Res 2007;9:doi:10.1186/bcr642.
13. John EM, Schwartz GG, Koo J, Wang W, Ingles SA. Sun exposure, vitamin Dreceptor gene polymorphisms, and breast cancer risk in a multi-ethnic population. Am J Epidemiol 2007;166:1409-19.
14. Abbas S, Nieters A, Linseisen J, et al. Vitamin Dreceptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk. Breast Cancer Res 2008;10:R31. Epub ahead of print.
15. Uitterlinden AG, Fang Y, van Meurs JBJ, et al. Genetics and biology of vitamin Dreceptor polymorphisms. Gene 2004;338:143-56.
16. Guy M, Lowe LC, Bretherton-Watt D, et al. Vitamin D receptor gene polymorphisms and breast cancer risk. Clin Cancer Res 2004;10:5472-81.
17. Ingles SA, Haile RW, Henderson BE, et al. Strength of linkage disequilibrium between two vitamin Drecep tor markers in five ethnic groups: implications for association studies. Cancer Epidemiol Biomarkers Prev 1997;6:93-8.
18. Slattery ML, Yakumo K, Hoffman M, Neuhausen S. Variants of the VDR gene and risk of colon cancer. Cancer Causes Control 2001;12:359-64.
19. Yamagata Z, Zhang Y, Asaka A. Association of breast cancer with vitamin Dreceptor gene polymorphism [abstract]. Am J Hum Genet 1997;61:A388.
20. Ruggiero M, Pacini S, Aterini S, Fallai C, Ruggiero C, Pacini P. Vitamin Drecep tor gene polymorphism is associated with metastatic breast cancer. Oncol Res 1998;10:43-6.
21. Trabert B, Malone KE, Daling JR, et al. Vitamin D receptor polymorphisms and breast cancer risk in a large population-based case-control study of Caucasian and African-American women. Breast Cancer Res 2007;9:R84. doi:10.1186/ber 1833.
22. Buyru N, Tezol A, Yosunkaya-Fenerci E, Dalay N. Vitamin D receptor gene polymorphisms in breast cancer. Exp Mol Med 2003;35:550-5.
23. Hou M, Tien Y, Lin G, et al. Association of vitamin Dreceptor gene polymorphism with sporadic breast cancer in Taiwanese patients. Breast Cancer Res Treat 2002;74:1-7.
24. Hunter DJ, Riboli E, Haiman CA, et al. A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer 2005;5:977-85.
25. Feigelson HS, Cox DG, Cann HM, et al. Haplotype analysis of the HSD17B1 gene and risk of breast cancer: a comprehensive approach to multicenter analyses of prospective cohort studies. Cancer Res 2006;66:2468-75.
26. Willett W, Stampfer MJ. Total energy intake: implications for epidemiologic analyses. Am J Epidemiol 1986;124:17-27.
27. Packer BR, Yeager M, Staats B, et al. SNP500 Cancer: a public resource for sequence validation and assay development for genetic variation in candidate genes. Nucleic Acids Res 2004;1:D528-32.
28. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539-58.
29. Zhou W, Heist RS, Liu G, et al. Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients. J Clin Oncol 2007;25:479-85.
30. Moan J, Porojnicu AC, Dahlback A, Setlow RB. Addressing the health benefits and risks, involving vitamin Dor skin cancer, of increased sun exposure. Proc Natl Acad Sci U S A 2008;105:668-73.
31. Porojnicu AC, Lagunova Z, Robsahm TE, Berg JP, Dahlback A, Moan J. Changes in risk of death from breast cancer with season and latitude. Breast Cancer Res Treat 2007;102:323-8.
32. Colston KW, Hansen CM. Mechanisms implicated in the growth regulatory effects of vitamin Din breast cancer. Endocr Relat Cancer 2002;9:45-59.
33. Porter PL, Lund MJ, Lin MG, et al. Racial differences in the expression of cell cycle-regulatory proteins in breast cancer. Cancer 2004;100:2533-42.
34. Chlebowski RT, Chen Z, Anderson GL, et al. Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst 2005;97:439-48.
35. Lipkin M, Newmark HL. Vitamin D, calcium, and prevention of breast cancer: a review. J Am Coll Nutr 1999;18:392-7S.
36. Holick M. Vitamin D. In: Shils ME, Olson JA, Shike M, Ross AC, editors. Modern nutrition in health and disease. 9th ed. Philadelphia (PA): Lippincott Williams & Wilkins; 1999.
37. Cross HS, Kallay E, Lechner D, Gerdenitsch W, Adlercreutz H, Armbrecht HJ. Phytoestrogens and vitamin Dmetab olism: a new concept for the prevention and therapy of colorectal, prostate, and mammary carcinomas. J Nutr 2004;134:1207-12S.
38. Kim HS, Newcomb PA, Ulrich CM, et al. Vitamin Drece ptor polymorphism and the risk of colorectal adenomas: evidence of interaction with dietary vitamin Dand calcium. Cancer Epidemiol Biomarkers Prev 2001;10:869-74.